Top

Published in:

01-03-2004 | Consensus Conference

Inhaled nitric oxide therapy in neonates and children: reaching a European consensus

Authors: Duncan J. Macrae, David Field, Jean-Christophe Mercier, Jens Møller, Tom Stiris, Paolo Biban, Paul Cornick, Allan Goldman, Sylvia Göthberg, Lars E. Gustafsson, Jürg Hammer, Per-Arne Lönnqvist, Manuel Sanchez-Luna, Gunnar Sedin, Nim Subhedar

Published in: Intensive Care Medicine | Issue 3/2004

Abstract

Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting.

Available only for authorised users

Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, Verter J, Stoll BJ, Lemons JA, Papile LA, Shankaran S, Donovan EF, Oh W, Ehrenkranz RA, Fanaroff AA (2000) Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105:14–20PubMed

Kinsella JP, Abman SH (1996) Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy. J Perinatol 16:S24–27PubMed

Kinsella JP, Abman SH (2000) Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr 136:717–726PubMed

Finer NN, Barrington KJ (2000) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev CD000399

Barefield ES, Karle VA, Phillips JB 3rd, Carlo WA (1996) Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr129:279–286

Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. ( 2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342:469–474PubMed

Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang CT (1998) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 101:325–334PubMed

Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S (2000) Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 28:3722–3727PubMed

Day RW, Lynch JM, White KS, Ward RM (1996) Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 98:698–705PubMed

10.

Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, de Lemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SA (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131:55–62PubMed

11.

The Neonatal Inhaled Nitric Oxide Study Group (NINOS) (1997) Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336:597–604PubMed

12.

Roberts JD Jr, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336:605–610

13.

Wessel DL, Adatia I, Van Marter LJ, Thompson JE, Kane JW, Stark AR, Kourembanas S (1997) Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 100:E7

14.

The Franco-Belgium Collaborative NO Trial Group (1999) Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet 354:1066–1071CrossRefPubMed

15.

Cornfield DN, Maynard RC, deRegnier RA, Guiang SF 3rd, Barbato JE, Milla CE (1999) Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics 104:1089–1094PubMed

16.

Sadiq F (1998) Illinois multicenter trial. Treatment of persistent pulmonary hypertension of the newborn with inhaled nitric oxide: a randomised trial. Pediatr Res 43:192A

17.

The Neonatal Inhaled Nitric Oxide Study Group (NINOS) (1997) Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia.. Pediatrics 99:838–845PubMed

18.

The Neonatal Inhaled Nitric Oxide Study Group (NINOS) (2000) Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 136:611–617CrossRefPubMed

19.

Henrichsen T, Goldman AP, Macrae DJ (1996) Inhaled nitric oxide can cause severe systemic hypotension. J Pediatr 129:183

20.

Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA (1994) Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 124:302–308PubMed

21.

Demirakca S, Dotsch J, Knothe C, Magsaam J, Reiter HL, Bauer J, Kuehl PG (1996) Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: dose response, prolonged inhalation and weaning. Crit Care Med 24:1913–1919CrossRefPubMed

22.

Lönnqvist PA, Winberg P, Lundell B, Sellden H, Olsson GL (1994) Inhaled nitric oxide in neonates and children with pulmonary hypertension. Acta Paediatr 83:1132–1136PubMed

23.

Tworetzky W, Bristow J, Moore P, Brook MM, Segal MR, Brasch RC, Hawgood S, Fineman JR (2001) Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Lancet 357:118–120CrossRefPubMed

24.

Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ (1996) Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 98:706–713PubMed

25.

Dotsch J, Demirakca S, Zepf K, Hanze J, Parida S, Rascher W (2000) Recovery from withdrawal of inhaled nitric oxide and kinetics of nitric oxide-induced inhibition of nitric oxide synthase activity in vitro. Intensive Care Med 26:330–335PubMed

26.

Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, Fineman JR (1999) Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol 277:H1849–H1856PubMed

27.

Petros AJ (1994) Down-regulation of endogenous nitric oxide production after prolonged administration. Lancet 344: 191CrossRef

28.

Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819–820PubMed

29.

Aly H, Sahni R, Wung JT (1997) Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed 76:F118–F122PubMed

30.

Sokol GM, Fineberg NS, Wright LL, Ehrenkranz RA (2001) Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide. Pediatr Pulmonol 32:14–19CrossRefPubMed

31.

Atz AM, Wessel DL (1999) Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91:307–310PubMed

32.

Rasmussen TR, Kjaergaard SK, Tarp U, Pedersen OF (1992) Delayed effects of NO₂ exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 146:654–659PubMed

33.

Anonymous (1988) Recommendations for occupational safety and health standards. MMWR 37:1–29

34.

Gries A, Herr A, Motsch J, Holzmann A, Weimann J, Taut F, Erbe N, Bode C, Martin E (2000) Randomized, placebo-controlled, blinded and cross-matched study on the antiplatelet effect of inhaled nitric oxide in healthy volunteers. Thromb Haemost 83:309–315PubMed

35.

Albert J, Norman M, Wallén NH, Frostell C, Hjemdahl P (1999) Inhaled nitric oxide does not influence bleeding time or platelet function in healthy volunteers. Eur J Clin Invest 29:953–959CrossRefPubMed

36.

Miller OI, Celermajer DS, Deanfield JE, Macrae DJ (1994) Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 70:F47–F49

37.

Francoe M, Troncy E, Blaise G (1998) Inhaled nitric oxide: technical aspects of administration and monitoring. Crit Care Med 26:782–796CrossRefPubMed

38.

Schedin U, Frostell CG, Gustafsson LE (1999) Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances. Br J Anaesth 82:182–192PubMed

39.

Kirmse M, Hess D, FujinoY, Kakmarek RM, Hurford WE (1998) Delivery of inhaled nitric oxide using the INOvent delivery system. Chest 113:1650–1657PubMed

40.

Stenqvist O, Kjelltoft B, Lundin S (1993) Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesth Scand 37:687–691PubMed

41.

Lindwall R, Frostell, CG, Lönnqvist PA (2002) Delivery characteristics of a combined nitric oxide continuous positive airway pressure system. Paediatr Anaesth 12(6):530–536CrossRefPubMed

42.

Anonymous (2000) Classification of nitric oxide administration apparatus, nitric oxide analysers and nitrogen dioxide analysers. H Final Rule. Fed Regist 65:11464–11465PubMed

43.

Squire S (1996) An effective method of scavenging nitric oxide (with personal communication from NHS Estates). Br J Anaesth 77:432–434PubMed

44.

Phillips ML, Hall TA, Sekar K, Tomey JL (1999) Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients. Pediatrics 104:1095–1100PubMed

45.

Goldman AP, Cook PD, Macrae DJ (1995) Exposure of intensive-care staff to nitric oxide and nitrogen dioxide. Lancet 345:199–200CrossRef

46.

Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH (1993) Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 123:103–108PubMed

47.

Kinsella JP, Schmidt JM, Griebel J, Abman SH (1995) Inhaled nitric oxide treatment for stabilization and emergency medical transport of critically ill newborns and infants. Pediatrics 95:773–776PubMed

48.

Kinsella JP, Griebel J, Schmidt JM, Abman SH (2002) Use of inhaled nitric oxide during interhospital transport of newborns with hypoxemic respiratory failure. Pediatrics 109:158–161PubMed

49.

Anonymous (2000) Equipped to care. The safe use of medical devices in the 21st century. Medical Devices Agency, London

50.

Anonymous (1999) Use of inhaled nitric oxide. Pediatrics 106:344–345

51.

Noel S (1999) Nitric oxide at work in the intensive care unit; implications for nursing practice. Nurs Crit Care 4:249–255

52.

Glynn G (1999) Nitric oxide: a nursing experience. J Neonatal Nurs 5:11–14

53.

Barrington KJ, Finer NN (2001) Inhaled nitric oxide for respiratory failure in preterm infants (Cochrane Review). Cochrane Database Syst Rev 4

54.

Subhedar NV, Ryan SW, Shaw NJ (1997) Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child 77:F185–F190

55.

Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SA (1999) Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 354:1061–1065CrossRefPubMed

56.

Hoehn T, Krause MF, Buhrer C (2000) Inhaled nitric oxide in premature infants—a meta-analysis. J Perinat Med 28:7–13PubMed

57.

Bennett AJ, Shaw NJ, Gregg JE, Subhedar NV (2001) Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide. Acta Paediatr 90:573–576CrossRefPubMed

58.

Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K Jr, Hyers TM, Papadakos P (1998) Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 26:15–23PubMed

59.

Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, Liu P, Eells PL, Griebel J, Baier M, Kinsells JP, Abman SH (1999) Multicenter randomized-controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxaemic respiratory failure. J Pediatr 134:406–412PubMed

60.

Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C (1999) Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 25:911–919PubMed

61.

Troncy E, Collet J-P, Shapiro S, Guimond JG, Blair L, Ducruet T, Francoeur M, Scharbonneau M, Blaise G (1998) Inhaled nitric oxide in acute respiratory distress syndrome: A pilot randomized controlled study. Am J Respir Crit Care 157:1483–1488PubMed

62.

Michael JR, Barton G, Saffle JR, Mone M, Markewitz BA, Hillier K, Elstad MR, Campbell EJ, Troyer BE, Whatley RE, Liou TG, Samuelson WM, Carveth HJ, Hinson DM, Morris SE, Davies BL, Day RW (1998) Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care 157:1372–1380PubMed

63.

Sokol J, Jacobs SE, Bohn D (2000) Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev CD002787

64.

Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ (1993) Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88:2128–2138PubMed

65.

Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL (1995) Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 25:1656–1664CrossRefPubMed

66.

Roberts JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM (1993) Inhaled nitric oxide in congenital heart disease. Circulation 87:447–453PubMed

67.

Miller OI, Celermajer DS, Deanfield JE, Macrae DJ (1994) Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 108:487–494PubMed

68.

Wessel DL (1993) Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass. Crit Care Med 21:S344–S345PubMed

69.

Wessel DL, Adatia I, Thompson JE, Hickey PR (1994) Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 22:930–938PubMed

70.

Goldman AP, Delius RE, Deanfield JE, Macrae DJ (1995) Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg 60:300–305; discussion 306CrossRefPubMed

71.

Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 356:1464–1469CrossRefPubMed

72.

Day RW, Hawkins JA, McGough EC, Crezee KL, Orsmond GS (2000) Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 69:1907–1912; discussion 1913CrossRefPubMed

73.

Goldman AP, Delius RE, Deanfield JE, Miller OI, de Leval MR, Sigston PE, Macrae DJ (1996) Pharmacological control of pulmonary blood flow with inhaled nitric oxide after the fenestrated Fontan operation. Circulation 94 (9 Suppl):II-44–II-48

74.

Schulze-Neick I, Bultmann M, Werner H, Gamillscheg A, Vogel M, Berger F, Rossaint R, Hetzer R, Lange PE (1997) Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital heart disease in newborns and children. Am J Cardiol 80:360–363CrossRefPubMed

Title: Inhaled nitric oxide therapy in neonates and children: reaching a European consensus
Authors: Duncan J. Macrae
David Field
Jean-Christophe Mercier
Jens Møller
Tom Stiris
Paolo Biban
Paul Cornick
Allan Goldman
Sylvia Göthberg
Lars E. Gustafsson
Jürg Hammer
Per-Arne Lönnqvist
Manuel Sanchez-Luna
Gunnar Sedin
Nim Subhedar
Publication date: 01-03-2004
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 3/2004
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-2122-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Inhaled nitric oxide therapy in neonates and children: reaching a European consensus

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2004

Dynamic elastic pressure-volume loops in healthy pigs recorded with inspiratory and expiratory sinusoidal flow modulation

Abstracts of the 16th Annual Congress of the European Society of Intensive Care Medicine, Amsterdam, Netherlands

Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs

RETRACTED ARTICLE: Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery

Lactic acidosis: An early marker of propofol infusion syndrome?

Relation of cerebral tissue oxygenation index to central venous oxygen saturation in children